Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Gastritis II: Pathophysiology01:26

Gastritis II: Pathophysiology

The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

VEXAS syndrome through a rheumatologist's lens: insights from a Spanish national cohort.

Rheumatology (Oxford, England)·2025
Same author

[Parry-Romberg syndrome].

Medicina clinica·2011
Same author

[Adult onset Still's disease: review of 26 cases].

Medicina clinica·2007
Same journal

Clinical validation of video DASH for upper limb disorders in rheumatic patients.

Reumatologia clinica·2026
Same journal

Coexistence of systemic lupus erythematosus and sarcoidosis: A case-based review.

Reumatologia clinica·2026
Same journal

Factors associated with the perception of body image in patients with psoriatic disease.

Reumatologia clinica·2026
Same journal

Anti-Mi-2-positive amyopathic dermatomyositis unveiled by a V-sign.

Reumatologia clinica·2026
Same journal

Antinuclear antibody detection beyond anti-dsDNA and anti-ENA: New insights from intact HEp-2 nucleus ELISA.

Reumatologia clinica·2026
Same journal

Long-term stability of autoantibody-based serological profiles in systemic lupus erythematosus.

Reumatologia clinica·2026
See all related articles

Related Experiment Video

Updated: May 29, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

[Recurrent aphthous stomatitis in Rheumatology].

Gabriel Riera Matute1, Elena Riera Alonso

  • 1Servei de Reumatologia, Centre d'Especialitats Güell, Hospital Universitari de Girona Doctor Josep Trueta, Girona, España. rieramatute.girona.ics@gencat.cat

Reumatologia Clinica
|September 20, 2011
PubMed
Summary
This summary is machine-generated.

Recurrent aphthous stomatitis involves recurring oral ulcers of unknown cause. Treatment focuses on symptom relief for this condition, distinct from aphthosis with identified underlying systemic diseases.

More Related Videos

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Related Experiment Videos

Last Updated: May 29, 2026

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK
07:27

Recurrent Herpetic Stromal Keratitis in Mice, a Model for Studying Human HSK

Published on: December 18, 2012

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients
05:26

Examination of Oral Candida Infection in Primary Sjögren's Syndrome Patients

Published on: March 1, 2024

Induction of Ocular Surface Inflammation and Collection of Involved Tissues
06:38

Induction of Ocular Surface Inflammation and Collection of Involved Tissues

Published on: August 4, 2022

Area of Science:

  • Oral pathology
  • Immunology
  • Dermatology

Context:

  • Recurrent aphthous stomatitis (RAS) is characterized by recurring oral ulcers.
  • The etiology of RAS remains largely unknown.
  • Clinical presentation varies in ulcer number, size, and healing time.

Purpose:

  • To differentiate recurrent aphthous stomatitis from other oral ulcerations.
  • To outline the diagnostic considerations based on clinical presentation and severity.
  • To describe current treatment strategies for RAS.

Summary:

  • RAS is defined by recurrent oral ulcers without a known specific cause.
  • Factors associated with outbreaks are noted but not causative.
  • Differential diagnosis relies on severity and clinical presentation.
  • Treatment for RAS is primarily symptomatic.
  • When oral aphthosis has a known etiology, it is not considered RAS and requires treatment of the underlying condition.

Impact:

  • Improved understanding of RAS diagnostic criteria.
  • Guidance on symptomatic management of recurrent oral ulcers.
  • Emphasis on distinguishing RAS from systemic disease-related aphthosis.
  • Foundation for future research into the unknown etiology of RAS.